{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:14:07Z","timestamp":1771326847048,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National key Research Program of China (973 Program)","award":["2017YFC0909002"],"award-info":[{"award-number":["2017YFC0909002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10067-020-05032-4","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T09:03:06Z","timestamp":1585213386000},"page":"2653-2661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dynamic changes in gut microbiota under the influence of smoking and TNF-\u03b1-blocker in patients with ankylosing spondylitis"],"prefix":"10.1007","volume":"39","author":[{"given":"Fangze","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuili","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"5032_CR1","doi-asserted-by":"publisher","unstructured":"Shreiner AB, Kao JY, Young VB (2015) The gut microbiome in health and in disease. Curr Opin Gastroenterol 31:69\u201375. https:\/\/doi.org\/10.1097\/MOG.0000000000000139","DOI":"10.1097\/MOG.0000000000000139"},{"key":"5032_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/PPO.0000000000000050","volume":"20","author":"S Dulal","year":"2014","unstructured":"Dulal S, Keku TO (2014) Gut microbiome and colorectal adenomas. Cancer J 20:225\u2013231. https:\/\/doi.org\/10.1097\/PPO.0000000000000050","journal-title":"Cancer J"},{"key":"5032_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.semarthrit.2019.05.007","volume":"49","author":"A Kalinkovich","year":"2019","unstructured":"Kalinkovich A, Livshits G (2019) A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies. Semin Arthritis Rheum 49:474\u2013484. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.05.007","journal-title":"Semin Arthritis Rheum"},{"key":"5032_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10067-017-3821-4","volume":"37","author":"D Zhong","year":"2018","unstructured":"Zhong D, Wu C, Zeng X, Wang Q (2018) The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol 37:25\u201334. https:\/\/doi.org\/10.1007\/s10067-017-3821-4","journal-title":"Clin Rheumatol"},{"key":"5032_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39259","volume":"68","author":"JU Scher","year":"2016","unstructured":"Scher JU, Littman DR, Abramson SB (2016) Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis Rheum 68:35\u201345. https:\/\/doi.org\/10.1002\/art.39259","journal-title":"Arthritis Rheum"},{"key":"5032_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1136\/ard.2003.011882","volume":"63","author":"A Martinez","year":"2004","unstructured":"Martinez A, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R (2004) Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis 63:1338\u20131340","journal-title":"Ann Rheum Dis"},{"key":"5032_CR7","doi-asserted-by":"publisher","unstructured":"Yang L, Wang L, Wang X, Xian CJ, Lu H (2016) A possible role of intestinal microbiota in the pathogenesis of ankylosing spondylitis. Int J Mol Sci 17(12):E2126. https:\/\/doi.org\/10.3390\/ijms17122126","DOI":"10.3390\/ijms17122126"},{"key":"5032_CR8","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1128\/IAI.67.6.2969-2974.1999","volume":"67","author":"HC Rath","year":"1999","unstructured":"Rath HC, Wilson KH, Sartor RB (1999) Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 67:2969\u20132974","journal-title":"Infect Immun"},{"key":"5032_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/ard.56.3.180","volume":"56","author":"O M\u00e4ki-Ikola","year":"1997","unstructured":"M\u00e4ki-Ikola O, Leirisalo-Repo M, Turunen U, Granfors K (1997) Association of gut inflammation with increased serum IgA class Klebsiella antibody concentrations in patients with axial ankylosing spondylitis (AS): implication for different aetiopathogenetic mechanisms for axial and peripheral AS? Ann Rheum Dis 56:180\u2013183","journal-title":"Ann Rheum Dis"},{"key":"5032_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/rheumatology\/33.7.644","volume":"33","author":"O Mart\u00ednez-Gonz\u00e1lez","year":"1994","unstructured":"Mart\u00ednez-Gonz\u00e1lez O, Cantero-Hinojosa J, Paule-Sastre P, G\u00f3mez-Mag\u00e1n JC, Salvatierra-R\u00edos D (1994) Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol 33:644\u2013647","journal-title":"Br J Rheumatol"},{"key":"5032_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-med-051914-021944","volume":"67","author":"GE Fragoulis","year":"2016","unstructured":"Fragoulis GE, Siebert S, McInnes IB (2016) Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases. Annu Rev Med 67:337\u2013353","journal-title":"Annu Rev Med"},{"key":"5032_CR12","doi-asserted-by":"publisher","first-page":"539282","DOI":"10.1155\/2012\/539282","volume":"2012","author":"T Rashid","year":"2012","unstructured":"Rashid T, Ebringer A (2012) Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. Autoimmune Dis 2012:539282. https:\/\/doi.org\/10.1155\/2012\/539282","journal-title":"Autoimmune Dis"},{"key":"5032_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00203-018-1506-2","volume":"200","author":"Z Savin","year":"2018","unstructured":"Savin Z, Kivity S, Yonath H, Yehuda S (2018) Smoking and the intestinal microbiome. Arch Microbiol 200:677\u2013684. https:\/\/doi.org\/10.1007\/s00203-018-1506-2","journal-title":"Arch Microbiol"},{"key":"5032_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/annrheumdis-2013-205133","volume":"75","author":"A Ciurea","year":"2016","unstructured":"Ciurea A, Acherer A, Weber U, Exer P, Bernhard J, Tamborrini G, Riek M, M\u00fcller RB, Weiss B, Nissen MJ, Kissling R, Michel BA, Finckh A (2016) Impaired response to treatment with tumour necrosis factor \u03b1 inhibitors in smokers with axial spondyloarthritis. Ann Rheum Dis 75:532\u2013539. https:\/\/doi.org\/10.1136\/annrheumdis-2013-205133","journal-title":"Ann Rheum Dis"},{"key":"5032_CR15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/acr.23157","volume":"69","author":"GT Jones","year":"2017","unstructured":"Jones GT, Ratz T, Dean LE, Macfariane GJ, Atzeni F (2017) Disease severity in never smokers, ex-smokers, and current smokers with axial spondyloarthritis: results from the Scotland registry for ankylosing spondylitis. Arthritis Care Res 69:1407\u20131413. https:\/\/doi.org\/10.1002\/acr.23157","journal-title":"Arthritis Care Res"},{"key":"5032_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"LS Van der","year":"1984","unstructured":"Van der LS, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"5032_CR17","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"5032_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/ard.62.9.817","volume":"62","author":"J Braun","year":"2003","unstructured":"Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D, ASAS Working Group (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62:817\u2013824","journal-title":"Ann Rheum Dis"},{"key":"5032_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D, Assessment of SpondyloArthritis international Society (2011) Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47\u201353. https:\/\/doi.org\/10.1136\/ard.2010.138594","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"5032_CR20","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewe R, Maksymoowych W, van der Heijde D (2009) The assessment of SpondyloArthritis international society (ASAS) hand book: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u2013i44. https:\/\/doi.org\/10.1136\/ard.2008.104018","journal-title":"Ann Rheum Dis"},{"key":"5032_CR21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar RC (2013) UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10:996\u2013998. https:\/\/doi.org\/10.1038\/nmeth.2604","journal-title":"Nat Methods"},{"key":"5032_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/17474124.2018.1505497","volume":"12","author":"B Laing","year":"2018","unstructured":"Laing B, Barnett MPG, Marlow G, Nasef NA, Ferguson LR (2018) An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets. Expert Rev Gastroenterol Hepatol 12:969\u2013983. https:\/\/doi.org\/10.1080\/17474124.2018.1505497","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5032_CR23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1136\/gutjnl-2012-303611","volume":"62","author":"V Eeckhaut","year":"2013","unstructured":"Eeckhaut V, Machiels K, Perrier C, Romero C, Maes S, Flahou B, Steppe M, Haesebrouck F, Sas B, Ducatelle R, Vermeire S, Van Immerseel F (2013) Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut. 62:1745\u20131752. https:\/\/doi.org\/10.1136\/gutjnl-2012-303611","journal-title":"Gut."},{"key":"5032_CR24","doi-asserted-by":"publisher","first-page":"F1000 faculty R","DOI":"10.12688\/f1000research.14956.1","volume":"7","author":"L Garcia-Montoya","year":"2018","unstructured":"Garcia-Montoya L, Gul H, Emery P (2018) Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Res 7:F1000 faculty Rev-1512. https:\/\/doi.org\/10.12688\/f1000research.14956.1 eCollection 2018","journal-title":"F1000Res"},{"key":"5032_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0016-5085(89)91557-6","volume":"96","author":"M De Vos","year":"1989","unstructured":"De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A (1989) Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 96:339\u2013344","journal-title":"Gastroenterology"},{"key":"5032_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.38967","volume":"67","author":"ME Costello","year":"2015","unstructured":"Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, Marshall M, Kenna TJ, Triolo G, Brown MA (2015) Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheum 67:686\u2013691. https:\/\/doi.org\/10.1002\/art.38967","journal-title":"Arthritis Rheum"},{"key":"5032_CR27","doi-asserted-by":"publisher","unstructured":"Van Praet L, Jans L, Carron P, Jacques P, Glorieus E, Colman R (2014) Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort. Ann Rheum Dis 73:1186\u20131189. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203854","DOI":"10.1136\/annrheumdis-2013-203854"},{"key":"5032_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","volume":"118","author":"TR Orchard","year":"2000","unstructured":"Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP (2000) Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118:274\u2013278","journal-title":"Gastroenterology"},{"key":"5032_CR29","doi-asserted-by":"publisher","unstructured":"Asquith M, Elewaut D, Lin P, Rosenbaum JT (2014) The role of the gut and microbes in the pathogenesis of spondyloarthritis. Best Pract Res Clin Rheumatol 28:687\u2013702. https:\/\/doi.org\/10.1016\/j.berh.2014.10.018","DOI":"10.1016\/j.berh.2014.10.018"},{"issue":"1","key":"5032_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3904\/kjim.2016.324","volume":"34","author":"YW Lee","year":"2019","unstructured":"Lee YW, Lee KM, Lee JM, Chung YY, Kim DB, Kim YJ, Chung WC, Paik CN (2019) The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. Korean J Intern Med 34(1):72\u201380. https:\/\/doi.org\/10.3904\/kjim.2016.324","journal-title":"Korean J Intern Med"},{"key":"5032_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.17305\/bjbms.2016.752","volume":"16","author":"A Duran","year":"2016","unstructured":"Duran A, Kobak S, Sen N, Aktakka S, Atabay T, Orman M (2016) Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis. Bosn J Basic Med Sci 16:71\u201374. https:\/\/doi.org\/10.17305\/bjbms.2016.752","journal-title":"Bosn J Basic Med Sci"},{"key":"5032_CR32","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00198-016-3489-7","volume":"27","author":"E Klingberg","year":"2016","unstructured":"Klingberg E, Olerod G, Hammarsten O, Forsblad-d'Elia H (2016) The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study. Osteoporos Int 27:2027\u20132033. https:\/\/doi.org\/10.1007\/s00198-016-3489-7","journal-title":"Osteoporos Int"},{"key":"5032_CR33","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/ibd.20920","volume":"15","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, McNicholl AG, Gomollon F (2009) Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Inlamm Bowel Dis 15:1746\u20131754. https:\/\/doi.org\/10.1002\/ibd.20920","journal-title":"Inlamm Bowel Dis"},{"key":"5032_CR34","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nmicrobiol.2017.26","volume":"2","author":"AG Wexler","year":"2017","unstructured":"Wexler AG, Goodman AL (2017) An Insider's perspective: Bacteroides as a window into the microbiome. Nat Microbiol 2:17026. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.26","journal-title":"Nat Microbiol"},{"key":"5032_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, Jin F, Qin B (2017) Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features. Sci China Life Sci 60:1223\u20131233. https:\/\/doi.org\/10.1007\/s11427-016-9001-4","journal-title":"Sci China Life Sci"},{"key":"5032_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Qu\u00e9vrain","year":"2016","unstructured":"Qu\u00e9vrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Berm\u00fadez-Humar\u00e1n LG, Pigneur B, Lequin O, Kharrat P, Thomas G, Rainteau D, Aubry C, Breyner N, Afonso C, Lavielle S, Grill JP, Chassaing G, Chatel JM, Trugnan G, Xavier R, Langella P, Sokol H, Seksik P (2016) Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 65:415\u2013425. https:\/\/doi.org\/10.1136\/gutjnl-2014-307649","journal-title":"Gut"},{"key":"5032_CR37","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.3748\/wjg.v24.i37.4254","volume":"24","author":"CS Wang","year":"2018","unstructured":"Wang CS, Li WB, Wang HY, Ma YM, Zhao XH, Yang H, Qian JM, Li JN (2018) VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. World J Gastroenterol 24:4254\u20134262. https:\/\/doi.org\/10.3748\/wjg.v24.i37.4254","journal-title":"World J Gastroenterol"},{"key":"5032_CR38","doi-asserted-by":"publisher","unstructured":"Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, Ojcius DM, Lu CC, Young JD, Lai HC (2019) Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 68:248\u2013262. https:\/\/doi.org\/10.1136\/gutjnl-2017-315458","DOI":"10.1136\/gutjnl-2017-315458"},{"issue":"8","key":"5032_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","volume":"21","author":"RR Jenq","year":"2015","unstructured":"Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, Docampo MD, Peled JU, Arpaia N, Cross JR, Peets TK, Lumish MA, Shono Y, Dudakov JA, Poeck H, Hanash AM, Barker JN, Perales MA, Giralt SA, Pamer EG, van den Brink MR (2015) Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant 21(8):1373\u20131383. https:\/\/doi.org\/10.1016\/j.bbmt.2015.04.016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"5032_CR40","doi-asserted-by":"publisher","first-page":"e00094","DOI":"10.1128\/mSystems.00094-18","volume":"3","author":"L Boesmans","year":"2018","unstructured":"Boesmans L, Valles-Colomer M, Wang J, Eeckhaut V, Falony G, Ducatelle R, Van Immerseel F, Raes J, Verbeke K (2018) Butyrate producers as potential next-generation probiotics: safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers. mSystems 3(6):e00094\u2013e00018. https:\/\/doi.org\/10.1128\/mSystems.00094-18","journal-title":"mSystems"},{"key":"5032_CR41","doi-asserted-by":"publisher","unstructured":"Kim D, Hofstaedter CE, Zhao C, Mattei L, Tanes C, Clarke E, Lauder A, Sherrill-Mix S, Chehoud C, Kelsen J, Conrad M, Collman RG, Baldassano R, Bushman FD, Bittinger K (2017) Optimizing methods and dodging pitfalls in microbiome research. Microbiome 5(1):52. https:\/\/doi.org\/10.1186\/s40168-017-0267-5","DOI":"10.1186\/s40168-017-0267-5"},{"issue":"1","key":"5032_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40168-018-0531-3","volume":"6","author":"ER Shanahan","year":"2018","unstructured":"Shanahan ER, Shah A, Koloski N, Walker MM, Talley NJ, Morrison M, Holtmann GJ (2018) Influence of cigarette smoking on the human duodenal mucosa-associated microbiota. Microbiome 6(1):150. https:\/\/doi.org\/10.1186\/s40168-018-0531-3","journal-title":"Microbiome"},{"issue":"9","key":"5032_CR43","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1097\/MIB.0000000000000875","volume":"22","author":"JL Opstelten","year":"2016","unstructured":"Opstelten JL, Plassais J, van Mil SW, Achouri E, Pichaud M, Siersema PD, Oldenburg B, Cervino AC (2016) Gut microbial diversity is reduced in smokers with Crohn\u2019s disease. Inflamm Bowel Dis 22(9):2070\u20132077. https:\/\/doi.org\/10.1097\/MIB.0000000000000875","journal-title":"Inflamm Bowel Dis"},{"key":"5032_CR44","doi-asserted-by":"publisher","first-page":"23561","DOI":"10.1038\/srep23561","volume":"6","author":"CS de Paiva","year":"2016","unstructured":"de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC (2016) Altered mucosal microbiome diversity and disease severity in Sj\u00f6gren syndrome. Sci Rep 6:23561. https:\/\/doi.org\/10.1038\/srep23561","journal-title":"Sci Rep"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-05032-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:46:06Z","timestamp":1616719566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-05032-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5032"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05032-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"9 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The ethics committee of the hospital approved this study (2016wjw009). All procedures were followed in accordance with the ethical standards of the Helsinki Declaration amended in 2008 and Good Clinical Practice standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants prior to their inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}